Sotera Health Company (SHC)

Form SD - Specialized disclosure report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form 424B7 - Prospectus [Rule 424(b)(7)]

Form 424B7 - Prospectus [Rule 424(b)(7)]

Sotera Health Announces Secondary Offering of Common Stock

CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025Q1 2026 net...

Sotera Health Announces Leadership Transition

Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26...

Sotera Health Announces First-Quarter 2026 Earnings Release Date

CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider...